PP_1170x120_10-25-21

Glenmark Pharmaceuticals Inc.

Glenmark gets ANDA approval for hydrocortisone valerate cream

Glenmark gets ANDA approval for hydrocortisone valerate cream

MUMBAI, India — Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for hydrocortisone valerate cream USP, 0.2%, a generic version of Westcort1 Cream, 0.2%, of Sun Pharmaceutical Industries Inc. According to IQVIATM sales data for the 12-month period ending August 2018, the Westcort

Glenmark gets approval for Estradiol Vaginal Inserts

Glenmark gets approval for Estradiol Vaginal Inserts

MUMBAI, India — Glenmark Pharmaceuticals Inc., USA  has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Estradiol Vaginal Inserts USP, 10 mcg, the generic version of Vagifem, 10 mcg, of Novo Nordisk Inc. According to IQVIATM sales data for the 12 month period ending July 2018, the Vagifem,

Glenmark gets approval for colesevelam hydrochloride tablets

Glenmark gets approval for colesevelam hydrochloride tablets

MUMBAI, India — Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (FDA) for colesevelam hydrochloride tablets, 625 mg, the generic version of Welchol Tablets, 625 mg, of Daiichi Sankyo Inc. The company has already commenced supplies of the product to the U.S. market. According to